Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-21 · accession 0001415889-23-006831 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-25 | 2023-04-21 | PTCT | Reeve Emma | Dir | S - Sale | $55.05 | -4,328 | 7,300 | -37% | -$238.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | S | D | 100 | $55.57 | 7,200 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-21 | S | D | 4,228 | $55.04 | 7,300 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.50 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |